The HMA:
- addresses key strategic issues for the network, such as exchange of information, IT developments and sharing of best practices
- focuses on the development, co-ordination and consistency of the European Medicines Regulatory System
- ensures the most effective and efficient use of resources across the network. This includes developing and overseeing arrangements for work-sharing
- co-ordinates the mutual recognition (MRP) and decentralised procedures (DCP).
Member agencies support the network by providing high-quality professional and scientific resources to all areas of medicines regulation including centralised, MRP, DCP and national procedures.